Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > News > pSivida's biosilicon does its job, then goes away

May 27th, 2005

pSivida's biosilicon does its job, then goes away

Abstract:
Howard Lovy: Every one of pSivida's first "customers," are going to die. And they're going to die of the disease that the Australian nanobio company's product is designed to treat. But if BrachySil, the company's lead product, gives liver cancer patients the gift of another year of life without the pain of chemotherapy, then that would count as pSivida's first success.

Source:
Howard Lovy's NanoBot

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Cellular environments shape molecular architecture: Researchers glean a more complete picture of a structure called the nuclear pore complex by studying it directly inside cells October 15th, 2021

How to program DNA robots to poke and prod cell membranes: A discovery of how to build little blocks out of DNA and get them to stick to lipids has implications for biosensing and mRNA vaccines October 15th, 2021

Directly into the brain: A 3D multifunctional and flexible neural interface: Novel design of brain chip implant allows for measuring neuronal activity while simultaneously delivering drugs to the implant site October 1st, 2021

New nano particles suppress resistance to cancer immunotherapy September 17th, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project